{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:15:42Z","timestamp":1740147342748,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11845-024-03679-5","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T06:19:47Z","timestamp":1711433987000},"page":"2077-2078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Angiotensin receptor blockers could be superior to angiotensin-converting enzyme inhibitors in COVID-19 management: the potential role of bradykinin"],"prefix":"10.1007","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-6025","authenticated-orcid":false,"given":"Mina T.","family":"Kelleni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"3679_CR1","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s11845-022-03096-6","volume":"192","author":"N Najafi","year":"2023","unstructured":"Najafi N, Davoudi A, Izadyar H et al (2023) The effect of ACE inhibitors and ARBs on outcomes in hospitalized patients with COVID-19. Ir J Med Sci 192:1517\u20131523","journal-title":"Ir J Med Sci"},{"key":"3679_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.703661","volume":"8","author":"R Singh","year":"2021","unstructured":"Singh R, Rathore SS, Khan H et al (2021) Mortality and severity in COVID-19 patients on ACEIs and ARBs-a systematic review, meta-analysis, and meta-regression analysis. Front Med (Lausanne) 8:703661","journal-title":"Front Med (Lausanne)"},{"key":"3679_CR3","doi-asserted-by":"publisher","first-page":"e019669","DOI":"10.1161\/JAHA.120.019669","volume":"10","author":"J An","year":"2021","unstructured":"An J, Wei R, Zhou H et al (2021) Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use and COVID-19 infection among 824 650 patients with hypertension from a US integrated healthcare system. J Am Heart Assoc 10:e019669","journal-title":"J Am Heart Assoc"},{"key":"3679_CR4","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s10787-020-00755-x","volume":"28","author":"MT Kelleni","year":"2020","unstructured":"Kelleni MT (2020) ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror. Inflammopharmacology 28:1477\u20131480","journal-title":"Inflammopharmacology"},{"key":"3679_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ahj.2022.04.001","volume":"249","author":"AVS Macedo","year":"2022","unstructured":"Macedo AVS, de Paula TC, Moll-Bernardes RJ et al (2022) Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: insights from the BRACE CORONA trial. Am Heart J 249:86\u201397","journal-title":"Am Heart J"},{"key":"3679_CR6","doi-asserted-by":"publisher","first-page":"105057","DOI":"10.1016\/j.micpath.2021.105057","volume":"158","author":"V Mariappan","year":"2021","unstructured":"Mariappan V, Manoharan PS, Pajanivel R et al (2021) Potential biomarkers for the early prediction of SARS-COV-2 disease outcome. Microb Pathog 158:105057","journal-title":"Microb Pathog"},{"key":"3679_CR7","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14796","volume":"9","author":"VT Karamyan","year":"2021","unstructured":"Karamyan VT (2021) Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19? Physiol Rep 9:e14796","journal-title":"Physiol Rep"},{"key":"3679_CR8","doi-asserted-by":"publisher","unstructured":"Szekacs B, Varbiro S, Debreczeni L (2021) High-dose ACEi might be harmful in COVID-19 patients with serious respiratory distress syndrome by leading to excessive bradykinin receptor activation. Physiol Int 108(1).\u00a0https:\/\/doi.org\/10.1556\/2060.2021.00007","DOI":"10.1556\/2060.2021.00007"},{"issue":"2","key":"3679_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/v13020309","volume":"13","author":"E Mansour","year":"2021","unstructured":"Mansour E, Palma AC, Ulaf RG et al (2021) Safety and outcomes associated with the pharmacological inhibition of the kinin-kallikrein system in severe COVID-19. Viruses 13(2):309","journal-title":"Viruses"},{"key":"3679_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.34172\/jcvtr.2022.30559","volume":"14","author":"A Hadadi","year":"2022","unstructured":"Hadadi A, Kazemian S, Shafie M et al (2022) Effects of angiotensin receptor blockers (ARBs) on clinical outcomes of patients with hypertension and COVID-19: a 7-month follow-up cohort study. J Cardiovasc Thorac Res 14:253\u2013257","journal-title":"J Cardiovasc Thorac Res"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03679-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-024-03679-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-024-03679-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T10:10:45Z","timestamp":1722507045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-024-03679-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["3679"],"URL":"https:\/\/doi.org\/10.1007\/s11845-024-03679-5","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2024,3,26]]},"assertion":[{"value":"20 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}